Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2022

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission File Number: 001-35992

Oracle Corporation

(Exact name of registrant as specified in its charter)

Delaware

54-2185193

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

2300 Oracle Way

Austin, Texas

78741

(Address of principal executive offices)

(Zip Code)

(737) 867-1000

(Registrant s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

3.125% senior notes due July 2025

ORCL

New York Stock Exchange

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

The number of shares of registrant s common stock outstanding as of March 7, 2022 was: 2,668,157,000.

Table of Contents

ORACLE CORPORATION

FORM 10-Q QUARTERLY REPORT

TABLE OF CONTENTS

Page

PART I.

FINANCIAL INFORMATION

Item 1.

Financial Statements (Unaudited)

Condensed Consolidated Balance Sheets as of February 28, 2022 and May 31, 2021

Condensed Consolidated Statements of Operations for the Three and Nine Months Ended February 28, 2022 and 2021

Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended February 28, 2022 and 2021

Condensed Consolidated Statements of Stockholders (Deficit) Equity for the Three and Nine Months Ended February 28, 2022 and 2021

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended February 28, 2022 and 2021

Notes to Condensed Consolidated Financial Statements

Item 2.

Management s Discussion and Analysis of Financial Condition and Results of Operations

26

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

45

Item 4.

Controls and Procedures

45

PART II.

OTHER INFORMATION

46

Item 1.

Legal Proceedings

46

Item 1A.

Risk Factors

46

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

46

Item 5.

Other Information

46

Item 6.

Exhibits

47

Signatures

48

Table of Contents

Cautionary Note on Forward-Looking Statements

For purposes of this Quarterly Report, the terms Oracle, we, us and our refer to Oracle Corporation and its consolidated subsidiaries. This Quarterly Report on Form 10-Q contains statements that are not historical in nature, are predictive in nature, or that depend upon or refer to future events or conditions or otherwise contain forward-looking statements within the meaning of Section 21 of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These include, among other things, statements regarding:

the possible impact of the Russia-Ukraine situation on our business, including our belief that our profitability and the generation of positive cash flow from our operations will not be jeopardized by the current situation

our expectations regarding the impacts on our business as a result of the global COVID-19 pandemic

our expectation that we may acquire companies, products, services and technologies to further our corporate strategy as compelling opportunities become available

our expectations regarding the proposed acquisition of Cerner Corporation

our expectation that, on a constant currency basis, our total cloud and license revenues generally will continue to increase due to expected growth in our cloud services and our license support offerings, and continued demand for our cloud license and on-premise license offerings

our expectation that substantially all of our customers will renew their license support contracts annually

our expectation that our hardware business will have lower operating margins as a percentage of revenues than our cloud and license business

our expectation that we will continue to make significant investments in research and development, and our belief that research and development efforts are essential to maintaining our competitive position

our expectation that our international operations will continue to provide a significant portion of our total revenues and expenses

our expectation that variable expenditures that were curtailed primarily in response to COVID-19 may normalize in future periods provided global economic and health conditions improve

our expectation that the proportion of our cloud services and license support revenues relative to our cloud license and on-premise license revenues, hardware revenues and services revenues will continue to increase

the sufficiency of our sources of funding for working capital, capital expenditures, contractual obligations, acquisitions, dividends, stock repurchases, debt repayments and other matters

our belief that we have adequately provided under U.S. generally accepted accounting principles for outcomes related to our tax audits and that the final outcome of our tax-related examinations, agreements or judicial proceedings will not have a material effect on our results of operations, our belief that our net deferred tax assets will likely be realized in the foreseeable future, and our expectations regarding the Build Back Better Act budget reconciliation bill

our belief that the outcome of certain legal proceedings and claims to which we are a party will not, individually or in the aggregate, result in losses that are materially in excess of amounts already recognized, if any

our expectation that certain litigation related charges will not recur

the possibility that certain legal proceedings to which we are a party could have a material impact on our financial position or results of operations

Table of Contents

the timing and amount of expenses we expect to incur

the cost savings we expect to realize pursuant to our Fiscal 2022 Oracle Restructuring Plan

declarations of future cash dividend payments and the timing and amount of future stock repurchases, including our expectation that the levels of our future stock repurchase activity may be modified in comparison to past periods in order to use available cash for other purposes

our expectations regarding the impact of recent accounting pronouncements on our consolidated financial statements

our expectation that, to the extent customers renew support contracts or cloud SaaS and IaaS contracts from companies that we have acquired prior to fiscal 2022, we will recognize revenues for the full contracts values over the respective renewal periods

our ability to predict revenues, particularly certain cloud license and on-premise license revenues and hardware revenues

the percentages of remaining performance obligations that we expect to recognize as revenues over respective future periods

as well as other statements regarding our future operations, financial condition and prospects, and business strategies. Forward-looking statements may be preceded by, followed by or include the words expects, anticipates, intends, plans, believes, seeks, strives, endeavors, estimates, will, should, is designed to and similar expressions. We claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to risks, uncertainties and assumptions about our business that could affect our future results and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in Risk Factors included in documents we file from time to time with the U.S. Securities and Exchange Commission (the SEC), including our Annual Report on Form 10-K for our fiscal year ended May 31, 2021 and our other Quarterly Reports on Form 10-Q filed by us in our fiscal 2022, which runs from June 1, 2021 to May 31, 2022.

We have no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or risks, except to the extent required by applicable securities laws. If we do update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. New information, future events or risks could cause the forward-looking events we discuss in this Quarterly Report not to occur. You should not place undue reliance on these forward-looking statements, which reflect our expectations only as of the date of this Quarterly Report.

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements (Unaudited)

ORACLE CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

As of February 28, 2022 and May 31, 2021

(Unaudited)

(in millions, except per share data)

February 28,

2022

May 31,

2021

ASSETS

Current assets:

Cash and cash equivalents

22,682

30,098

Marketable securities

707

16,456

Trade receivables, net of allowances for doubtful accounts of $367 and $373 as of February 28, 2022 and May 31, 2021, respectively

4,588

5,409

Prepaid expenses and other current assets

3,698

3,604

Total current assets

31,675

55,567

Non-current assets:

Property, plant and equipment, net

8,609

7,049

Intangible assets, net

1,688

2,430

Goodwill, net

43,833

43,935

Deferred tax assets

13,109

13,636

Other non-current assets

9,730

8,490

Total non-current assets

76,969

75,540

Total assets

108,644

131,107

LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY

Current liabilities:

Notes payable, current

6,248

8,250

Accounts payable

1,124

745

Accrued compensation and related benefits

1,626

2,017

Deferred revenues

7,871

8,775

Other current liabilities

3,964

4,377

Total current liabilities

20,833

24,164

Non-current liabilities:

Notes payable and other borrowings, non-current

72,165

75,995

Income taxes payable

12,168

12,345

Deferred tax liabilities

6,462

7,864

Other non-current liabilities

5,227

4,787

Total non-current liabilities

96,022

100,991

Commitments and contingencies

Oracle Corporation stockholders (deficit) equity:

Preferred stock, $0.01 par value authorized: 1.0 shares outstanding: none

Common stock, $0.01 par value and additional paid in capital authorized: 11,000 shares outstanding: 2,668 shares and 2,814 shares as of February 28, 2022 and May 31, 2021, respectively

26,129

26,533

Accumulated deficit

(33,147

(20,120

Accumulated other comprehensive loss

(1,678

(1,175

Total Oracle Corporation stockholders (deficit) equity

(8,696

5,238

Noncontrolling interests

485

714

Total stockholders (deficit) equity

(8,211

5,952

Total liabilities and stockholders (deficit) equity

108,644

131,107

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the Three and Nine Months Ended February 28, 2022 and 2021

(Unaudited)

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions, except per share data)

2022

2021

2022

2021

Revenues:

Cloud services and license support

7,637

7,252

22,562

21,311

Cloud license and on-premise license

1,289

1,276

3,339

3,254

Hardware

798

820

2,328

2,478

Services

789

737

2,371

2,209

Total revenues

10,513

10,085

30,600

29,252

Operating expenses:

Cloud services and license support(1)

1,305

1,064

3,778

3,139

Hardware(1)

244

230

718

719

Services

669

621

1,984

1,875

Sales and marketing(1)

2,004

1,915

5,811

5,605

Research and development

1,816

1,621

5,254

4,812

General and administrative

335

330

953

949

Amortization of intangible assets

279

347

882

1,037

Acquisition related and other

20

13

4,707

107

Restructuring

19

66

89

337

Total operating expenses

6,691

6,207

24,176

18,580

Operating income

3,822

3,878

6,424

10,672

Interest expense

(667

(585

(2,051

(1,799

Non-operating expenses, net

(315

(17

(348

(30

Income before income taxes

2,840

3,276

4,025

8,843

(Provision for) benefit from income taxes

(521

1,745

(497

871

Net income

2,319

5,021

3,528

9,714

Earnings per share:

Basic

0.87

1.72

1.30

3.26

Diluted

0.84

1.68

1.26

3.19

Weighted average common shares outstanding:

Basic

2,670

2,913

2,711

2,977

Diluted

2,754

2,994

2,800

3,049

(1)

Exclusive of amortization of intangible assets, which is shown separately.

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the Three and Nine Months Ended February 28, 2022 and 2021

(Unaudited)

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions)

2022

2021

2022

2021

Net income

2,319

5,021

3,528

9,714

Other comprehensive (loss) income, net of tax:

Net foreign currency translation (losses) gains

(63

132

(508

504

Net unrealized gains on defined benefit plans

10

66

Net unrealized losses on marketable securities

(4

(1

Net unrealized losses on cash flow hedges

(7

(8

Total other comprehensive (loss) income, net

(62

131

(503

561

Comprehensive income

2,257

5,152

3,025

10,275

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS (DEFICIT) EQUITY

For the Three and Nine Months Ended February 28, 2022 and 2021

(Unaudited)

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions, except per share data)

2022

2021

2022

2021

Common stock and additional paid in capital

Balance, beginning of period

25,591

26,298

26,533

26,486

Common stock issued

52

143

357

915

Stock-based compensation

674

479

1,900

1,395

Repurchases of common stock

(65

(567

(1,648

(1,922

Other, net

(123

(92

(1,013

(613

Balance, end of period

26,129

26,261

26,129

26,261

Accumulated deficit

Balance, beginning of period

(34,076

(17,095

(20,120

(12,696

Repurchases of common stock

(535

(3,433

(13,952

(11,078

Cash dividends declared

(855

(699

(2,603

(2,146

Net income

2,319

5,021

3,528

9,714

Balance, end of period

(33,147

(16,206

(33,147

(16,206

Other stockholders (deficit) equity, net

Balance, beginning of period

(1,173

(587

(461

(1,073

Other comprehensive (loss) income, net

(62

131

(503

561

Other, net

42

38

(229

94

Balance, end of period

(1,193

(418

(1,193

(418

Total stockholders (deficit) equity

(8,211

9,637

(8,211

9,637

Cash dividends declared per common share

0.32

0.24

0.96

0.72

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended February 28, 2022 and 2021

(Unaudited)

Nine Months Ended

February 28,

(in millions)

2022

2021

Cash flows from operating activities:

Net income

3,528

9,714

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

1,409

1,127

Amortization of intangible assets

882

1,037

Deferred income taxes

(983

(2,475

Stock-based compensation

1,900

1,395

Other, net

82

227

Changes in operating assets and liabilities, net of effects from acquisitions:

Decrease in trade receivables, net

652

1,089

Decrease in prepaid expenses and other assets

71

609

Decrease in accounts payable and other liabilities

(683

(247

Decrease in income taxes payable

(661

(1,181

Decrease in deferred revenues

(643

(250

Net cash provided by operating activities

5,554

11,045

Cash flows from investing activities:

Purchases of marketable securities and other investments

(10,134

(26,775

Proceeds from sales and maturities of marketable securities and other investments

25,735

19,035

Acquisitions, net of cash acquired

(132

(29

Capital expenditures

(3,088

(1,418

Net cash provided by (used for) investing activities

12,381

(9,187

Cash flows from financing activities:

Payments for repurchases of common stock

(15,654

(12,958

Proceeds from issuances of common stock

357

915

Shares repurchased for tax withholdings upon vesting of restricted stock-based awards

(1,011

(597

Payments of dividends to stockholders

(2,603

(2,146

Repayments of borrowings

(5,750

(2,631

Other, net

(439

241

Net cash used for financing activities

(25,100

(17,176

Effect of exchange rate changes on cash and cash equivalents

(251

400

Net decrease in cash and cash equivalents

(7,416

(14,918

Cash and cash equivalents at beginning of period

30,098

37,239

Cash and cash equivalents at end of period

22,682

22,321

Non-cash financing activities:

Change in unsettled repurchases of common stock

(54

42

See notes to condensed consolidated financial statements.

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

February 28, 2022

(Unaudited)

1.

BASIS OF PRESENTATION, RECENT ACCOUNTING PRONOUNCEMENTS AND OTHER

Basis of Presentation

We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures herein are adequate to ensure the information presented is not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2021.

We believe that all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the operating results to be expected for any subsequent interim period or for our fiscal year ending May 31, 2022.

The comparability of our condensed consolidated financial statements as of and for the nine months ended February 28, 2022 was impacted by $4.7 billion of certain litigation related charges that are more fully described in Note 11 below. The comparability of our condensed consolidated financial statements for the three and nine months ended February 28, 2021 was impacted by a $2.3 billion net income tax benefit related to the partial realignment of our legal entity structure that resulted in the intra-group transfer of certain intellectual property rights (refer to Notes 1 and 14 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended May 31, 2021 for additional information).

During the first nine months of fiscal 2022, we adopted Accounting Standards Update (ASU) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes and ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, neither of which had a material impact to our condensed consolidated financial statements as of and for the nine months ended February 28, 2022. There have been no changes to our significant accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended May 31, 2021 that had a significant impact on our condensed consolidated financial statements or notes thereto as of and for the nine months ended February 28, 2022.

Cash, Cash Equivalents and Restricted Cash

Restricted cash that was included within cash and cash equivalents as presented within our condensed consolidated balance sheets as of February 28, 2022 and May 31, 2021 and our condensed consolidated statements of cash flows for the nine months ended February 28, 2022 and 2021 was nominal.

Remaining Performance Obligations from Contracts with Customers

Trade receivables, net of allowance for doubtful accounts, and deferred revenues are reported net of related uncollected deferred revenues in our condensed consolidated balance sheets as of February 28, 2022 and May 31, 2021. The revenues recognized during the nine months ended February 28, 2022 and 2021, respectively, that were included in the opening deferred revenues balances as of May 31, 2021 and 2020, respectively, were approximately $8.1 billion and $7.4 billion, respectively. Revenues recognized from performance obligations satisfied in prior periods and impairment losses recognized on our receivables were immaterial in each of the three and nine months ended February 28, 2022 and 2021, respectively.

Remaining performance obligations, as defined in Note 1 of Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended May 31, 2021, were $38.5 billion as of February 28,

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

February 28, 2022

(Unaudited)

2022, approximately 59% of which we expect to recognize as revenues over the next twelve months, 30% over the subsequent month 13 to month 36, and the remainder thereafter.

Sales of Financing Receivables

We offer certain of our customers the option to acquire certain of our cloud and license, hardware and services offerings through separate long-term payment contracts. We generally sell these contracts that we have financed for our customers on a non-recourse basis to financial institutions within 90 days of the contracts dates of execution. We record the transfers of amounts due from customers to financial institutions as sales of financing receivables because we are considered to have surrendered control of these financing receivables. Financing receivables sold to financial institutions were $352 million and $1.4 billion for the three and nine months ended February 28, 2022, respectively, and $338 million and $1.3 billion for the three and nine months ended February 28, 2021, respectively.

Non-Marketable Investments

Our non-marketable debt investments and equity securities and related instruments totaled $1.3 billion and $971 million as of February 28, 2022 and May 31, 2021, respectively, and are included either in other current assets or in other non-current assets in the accompanying consolidated balance sheets and are subject to periodic impairment reviews. Certain of these instruments are adjusted for observable price changes from orderly transactions. The substantial majority of the non-marketable debt investments and equity securities and related instruments held as of these dates were with a related party entity for which we follow the equity method of accounting. We are also a counterparty to certain options to acquire additional equity interests in that entity at various times through December 2023 and we could obtain control of that entity should such options be exercised.

Acquisition Related and Other Expenses

Acquisition related and other expenses consist of personnel related costs for transitional and certain other employees, certain business combination adjustments, including adjustments after the measurement period has ended, and certain other operating items, net. For the nine months ended February 28, 2022, acquisition related and other expenses included certain litigation related charges that we generally do not expect to recur as further described in Note 11 below.

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions)

2022

2021

2022

2021

Transitional and other employee related costs

Business combination adjustments, net

Other, net

13

10

4,693

100

Total acquisition related and other expenses

20

13

4,707

107

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

February 28, 2022

(Unaudited)

Non-Operating Expenses, net

Non-operating expenses, net consists primarily of interest income, net foreign currency exchange losses, the noncontrolling interests in the net profits of our majority-owned subsidiaries (primarily Oracle Financial Services Software Limited and Oracle Corporation Japan) and net other income and expenses, including net realized gains and losses related to all of our investments, net unrealized gains and losses related to the small portion of our investment portfolio related to our deferred compensation plan, net unrealized gains and losses related to equity securities, losses attributable to equity method investments, and non-service net periodic pension income and losses.

Three Months Ended

February 28,

Nine Months Ended

February 28,

(in millions)

2022

2021

2022

2021

Interest income

16

23

56

80

Foreign currency losses, net

(29

(18

(109

(84

Noncontrolling interests in income

(42

(46

(131

(127

Other, net

(260

24

(164

101

Total non-operating expenses, net

(315

(17

(348

(30

Recent Accounting Pronouncements

Financial Instruments: In March 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting and also issued subsequent amendments to the initial guidance (collectively, Topic 848). Topic 848 provides optional guidance for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. We will adopt Topic 848 when our relevant contracts are modified upon transition to alternative reference rates and expect this to occur through December 31, 2022. We do not expect our adoption of Topic 848 to have a material impact on our consolidated financial statements.

2.

ACQUISITIONS

Proposed Acquisition of Cerner Corporation

On December 20, 2021, we entered into an Agreement and Plan of Merger (Merger Agreement) with Cerner Corporation (Cerner), a provider of digital information systems used within hospitals and health systems that are designed to enable medical professionals to deliver better healthcare to individual patients and communities.

On January 19, 2022, pursuant to the Merger Agreement, we commenced a tender offer to purchase all of the issued and outstanding shares of common stock of Cerner at a purchase price of $95.00 per share, net to the seller in cash, without interest thereon, based upon the terms and subject to the conditions set forth in the Offer to Purchase (Offer) dated January 19, 2022, and the related Letter of Transmittal. The tender offer period is scheduled to expire on March 16, 2022 however, the parties anticipate extending the tender offer period to allow additional time for the satisfaction of the remaining conditions to the tender offer. The consummation of the Offer is subject to the valid tender of a majority of the aggregate number of issued and outstanding Cerner shares. On February 23, 2022, the waiting period expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, but the consummation of the Offer remains conditioned on: (i) receipt of certain regulatory approvals and, if applicable, approval under certain other foreign antitrust laws and (ii) other customary conditions. After the consummation of the Offer and the satisfaction of certain conditions, a wholly-owned subsidiary of Oracle will merge with and into Cerner. In addition, the unvested equity awards to acquire Cerner common stock that were outstanding immediately prior to the consummation of the merger will generally be assumed by Oracle and

10

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

February 28, 2022

(Unaudited)

converted into equity awards denominated in shares of Oracle common stock based on formulas contained in the Merger Agreement. Vested equity awards outstanding immediately prior to the consummation of the merger generally will be cancelled in exchange for the right to receive an amount in cash based on a formula contained in the Merger Agreement. The preliminary estimated total purchase price for Cerner is approximately $28.5 billion.

Other Fiscal 2022 and 2021 Acquisitions

During the first nine months of fiscal 2022 and full year fiscal 2021, we acquired certain other companies and purchased certain technology and development assets primarily to expand our products and services offerings. These acquisitions were not significant individually or in the aggregate to our condensed consolidated financial statements.

3.

FAIR VALUE MEASUREMENTS

We perform fair value measurements in accordance with FASB Accounting Standards Codification (ASC) 820, Fair Value Measurement. ASC 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at their fair values, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the assets or liabilities, such as inherent risk, transfer restrictions and risk of nonperformance.

ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset s or a liability s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:

Level 1: quoted prices in active markets for identical assets or liabilities

Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities or

Level 3: unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.

11

Table of Contents

ORACLE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

February 28, 2022

(Unaudited)

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Our assets and liabilities measured at fair value on a recurring basis consisted of the following (Level 1 and Level 2 inputs are defined above):

February 28, 2022

May 31, 2021

Fair Value Measurements

Using Input Types

Fair Value Measurements

Using Input Types

(in millions)

Level 1

Level 2

Total

Level 1

Level 2

Total

Assets:

Money market funds

12,877

12,877

12,263

12,263

Corporate debt securities and other

275

440

715

1,250

8,220

9,470

Commercial paper debt securities

11,712

11,712

Derivative financial instruments

73

73

Total assets

13,152

440

13,592

13,513

20,005

33,518

Liabilities:

Derivative financial instruments

33

33

We classify our marketable debt securities as available-for-sale securities at the time of purchase and reevaluate such classification as of each balance sheet date. Our marketable securities investments consist of money market funds, Tier 1 commercial paper debt securities, corporate debt securities and certain other securities. Marketable securities as presented per our condensed consolidated balance sheets included debt securities with original maturities at the time of purchase greater than three months and the remainder of the debt securities were included in cash and cash equivalents. As of February 28, 2022 and May 31, 2021, substantially all of our marketable debt securities investments mature within one year. Our valuation techniques used to measure the fair values of our instruments that were classified as Level 1 in the table above were derived from quoted market prices and active markets for these instruments that exist. Our valuation techniques used to measure the fair values of Level 2 instruments listed in the table above were derived from the following: non-binding market consensus prices that were corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques, with all significant inputs derived from or corroborated by observable market data including reference rate yield curves, among others.

Based on the trading prices of the $78.4 billion and $84.2 billion of senior notes and the related fair value hedges that we had outstanding as of February 28, 2022 and May 31, 2021, respectively, the estimated fair values of the senior notes and the related fair value hedges using Level 2 inputs at February 28, 2022 and May 31, 2021 were $76.6 billion and $89.6 billion, respectively.

12

Table of Contents

ORACLE CORPORATION